FDA Inspection 1099755 — Idaho Center for Reproductive Medicine
The FDA completed an inspection of Idaho Center for Reproductive Medicine on July 10, 2019 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Boise, ID (United States)